The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.
Decentralisation of clinical trials has been a growing topic of discussion and development over the last few years, enabled further by the advancement of available technologies. Here, we explore what we mean when we talk about decentralised trials and discuss why the clinical research industry has been reluctant to pursue this route. We illuminate the […]
During the coronavirus pandemic we made alternative arrangements for a patient visit where the patient was not comfortable travelling to the clinical trial site and did not want study staff in their home.
We explore how to look beyond the most common challenges faced by study organisers, and identify whether a clinical trial is an appropriate candidate for either a fully decentralised or hybrid model.
Our webinar panel discussed the challenges with new clinical trial technologies and how to deploy technologies that can deliver greater patient insight and engagement to ultimately improve patients’ safety and their trial experience.
We investigate the benefits of using wearable devices for patients taking part in clinical trials, as well as the challenges this new technology presents for clinical research.
